A Study of the Changes in Nutrition Status of Patients with Acute Myeloid Leukemia
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 16-009466
Sponsor Protocol Number: 16-009466
About this study
The purpose of this study is to determine best practices for the assessment and timing of nutrition interventions in patients who have Acute Myeloid Leukemia (AML).
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria
- Adult (≥ 18)
- Hem 2 service
- Diagnosis of acute myeloid leukemia (AML)
- Can understand spoken and written English
Exclusion Criteria
- Pediatric patients (<18)
- Diagnosis other than acute myeloid leukemia (AML)
- Cannot read and understand English
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Joy Heimgartner, M.S., RDN, LD |
Closed for enrollment |
|
More information
Publications
Publications are currently not available